Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Small Cap Growth Fund” second-quarter ...

Cellebrite DI announced its half-year 2025 results, reporting revenue of US$220.83 million, a turnaround to net income of US$36.88 million, and the appointment of Thomas E. Hogan as CEO, following his ...

Greenhaven Road Capital, an investment management company, released its second-quarter 2025 investor letter. A copy of the ...

We recently published 10 Stocks Crushing While Wall Street Naps. Cellebrite DI Ltd. (NASDAQ:CLBT) is one of the top ...

Cellebrite (CLBT) boasts strong growth potential with robust financials, digital forensics leadership, and a durable moat.

Investors in Cellebrite DI Ltd (Symbol: CLBT) saw new options become available this week, for the May 17th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ...

Cellebrite DI Ltd. (CLBT) key stats comparison: compare with other stocks by metrics: valuation, growth, profitability, momentum, EPS revisions, dividends, ratings.

For comparison, CLBT has a P/B of 34.06. These metrics, and several others, help IQV earn a Value grade of B, while CLBT has been given a Value grade of C.

Cellebrite DI Ltd. Annual stock financials by MarketWatch. View the latest CLBT financial statements, income statements and financial ratios.

Cellebrite DI Ltd. Annual cash flow by MarketWatch. View CLBT net cash flow, operating cash flow, operating expenses and cash dividends.